Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mauser

Showing results (131-140 of 166) with videos related to

Pageof 17
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 3, 2011
An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studiesE P Mauser-Bunschoten, I Kleine Budde, S Lopaciuk, et al.
American Journal of Hematology|September 17, 2015
Bleeding spectrum in children with moderate or severe von Willebrand disease: Relevance of pediatric-specific bleedingYvonne V Sanders, Karin Fijnvandraat, Johan Boender, et al.
Thrombosis and Haemostasis|May 6, 1998
Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors OrganisationC R Hay, C A Ludlam, B T Colvin, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 8, 2014
[Von Willebrand disease in the Netherlands: the WiN study]Yvonne V Sanders, Eva M de Wee, Karina Meijer, et al.
Blood|February 13, 2015
von Willebrand factor propeptide and the phenotypic classification of von Willebrand diseaseYvonne V Sanders, Dafna Groeneveld, Karina Meijer, et al.
Thrombosis and Haemostasis|January 6, 2018
Circulating Angiogenic Mediators in Patients with Moderate and Severe von Willebrand Disease: A Multicentre Cross-Sectional StudyDafna J Groeneveld, Yvonne V Sanders, Jelle Adelmeijer, et al.
Journal of Thrombosis and Haemostasis : JTH|December 21, 2010
Impact of von Willebrand disease on health-related quality of life in a pediatric populationE M de Wee, K Fijnvandraat, A de Goede-Bolder, et al.
Journal of Thrombosis and Haemostasis : JTH|April 23, 2014
von Willebrand disease and aging: an evolving phenotypeY V Sanders, M A Giezenaar, B A P Laros-van Gorkom, et al.
Thrombosis and Haemostasis|September 28, 2011
Gynaecological and obstetric bleeding in moderate and severe von Willebrand diseaseE M De Wee, H M Knol, E P Mauser-Bunschoten, et al.
Thrombosis and Haemostasis|October 2, 2018
Long-Term Outcome after Joint Bleeds in Von Willebrand Disease Compared to Haemophilia A: A Post Hoc AnalysisKarin P M van Galen, Merel Timmer, Piet de Kleijn, et al.
Pageof 17

Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 3, 2011
An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studiesE P Mauser-Bunschoten, I Kleine Budde, S Lopaciuk, et al.
American Journal of Hematology|September 17, 2015
Bleeding spectrum in children with moderate or severe von Willebrand disease: Relevance of pediatric-specific bleedingYvonne V Sanders, Karin Fijnvandraat, Johan Boender, et al.
Thrombosis and Haemostasis|May 6, 1998
Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors OrganisationC R Hay, C A Ludlam, B T Colvin, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 8, 2014
[Von Willebrand disease in the Netherlands: the WiN study]Yvonne V Sanders, Eva M de Wee, Karina Meijer, et al.
Blood|February 13, 2015
von Willebrand factor propeptide and the phenotypic classification of von Willebrand diseaseYvonne V Sanders, Dafna Groeneveld, Karina Meijer, et al.
Thrombosis and Haemostasis|January 6, 2018
Circulating Angiogenic Mediators in Patients with Moderate and Severe von Willebrand Disease: A Multicentre Cross-Sectional StudyDafna J Groeneveld, Yvonne V Sanders, Jelle Adelmeijer, et al.
Journal of Thrombosis and Haemostasis : JTH|December 21, 2010
Impact of von Willebrand disease on health-related quality of life in a pediatric populationE M de Wee, K Fijnvandraat, A de Goede-Bolder, et al.
Journal of Thrombosis and Haemostasis : JTH|April 23, 2014
von Willebrand disease and aging: an evolving phenotypeY V Sanders, M A Giezenaar, B A P Laros-van Gorkom, et al.
Thrombosis and Haemostasis|September 28, 2011
Gynaecological and obstetric bleeding in moderate and severe von Willebrand diseaseE M De Wee, H M Knol, E P Mauser-Bunschoten, et al.
Thrombosis and Haemostasis|October 2, 2018
Long-Term Outcome after Joint Bleeds in Von Willebrand Disease Compared to Haemophilia A: A Post Hoc AnalysisKarin P M van Galen, Merel Timmer, Piet de Kleijn, et al.
Pageof 17